https://www.selleckchem.com/pr....oducts/gsk269962.htm
Both groups were compared to a matched historical cohort (HC), which received only 30 minutes of upper-limb therapy per day. There were no significant between-group differences in FM-UE change or any of the secondary outcomes at any timepoint. Both high-dose groups showed greater recovery on the ARAT (7.3 ± 2.9 points; = .011) but not the FM-UE (1.4 ± 2.6 points; = .564) when compared with the HC. Neuroanimation may offer a new, enjoyable, efficient, and scalable way to deliver high-dose and intensive upper-limb therapy. Neuroanimatio
Like
Comment
Share
